Portfolio

RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies. Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. 

Select to filter companies by category

Active Companies

Amplyx Pharmaceuticals, Inc.
Arch Oncology, Inc.
Archmont Biopharma, Inc.
Avalyn Pharma, Inc.
Cardialen, Inc.
Good Therapeutics, Inc.
InterVene, Inc.
Neuros Medical, Inc.
OncoResponse, Inc.
OxaluRx, Inc.
Reneo Pharmaceuticals, Inc.
Scout Bio, Inc.
Spruce Biosciences, Inc.
Standard Bariatrics, Inc.
VentureMed Group, Inc.
Wugen, Inc.
Xilio Therapeutics

Exited Companies

Allakos, Inc.
Cabrellis Pharmaceuticals Corporation
Cameron Health, Inc.
Centerre Healthcare Corporation
CGI Pharmaceuticals Inc.
Conforma Therapeutics Corporation
Curzion Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc.
IDEV Technologies, Inc.
Lumena Pharmaceuticals, Inc.
Lutonix, Inc.
MacroGenics, Inc.
Mirum Pharmaceuticals, Inc.
Mpex Pharmaceuticals, Inc.
Otonomy, Inc.
Salient Surgical Technologies, Inc.
Securus Medical Group, Inc.
Velocimed, LLC
ZS Pharma Inc.
Map
MapMapMapMapMapMap
RiverVest’s Footprint Increases Its Opportunity Set

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Learn More